Maria Begoña Criado

Prof. Maria Begoña Criado

Toxicology Research Unit, University Institute of Health Sciences, Cooperativa de Ensino Superior Politécnico e Universitário-CESPU, 4585-116 Gandra, Portugal
orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2003 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
Lúcio Lara SantosLúcio Lara Santos
Lúcio Lara Santos
TATeresina Amaro
Teresina Amaro
CCCéu Costa
Céu Costa
SPSofia Pereira
Sofia Pereira
MBMaria José Bento
Maria José Bento
CLCarlos Lopes
Carlos Lopes
Approximately 80% of bladder tumors are urothelial superficial papillary carcinomas (USPC). Despite a generally good prognosis, these tumors have a strong propensity to recur and about 1/3 of them compared to disease progression. Histological assessment of these superficial tumors is not sufficiently discriminator in predicting prognosis; therefore, we decided to evaluate the prognostic significance of p53 and Ki‐67 immunoexpression in low‐grade (GI‐II) USPC in order to predict the potential outcome of these tumors. P53 and Ki‐67 immunoexpression were studied in function of recurrence‐free and progression‐free survival in 159 primary superficial bladder tumors. A prognostic risk model based on grade, stage and multifocality was also evaluated. P53 accumulation was significantly related to tumor progression (p=0.006). High Ki‐67 index (≥18%) and multifocality were significantly related to recurrence (both p=0.0001) and progression‐free survival (both p=0.0001) and were independent prognostic factors in the multivariate analysis. The prognostic risk model based on grade, stage and multifocality was not an efficient discriminator of outcome. Adding the Ki‐67 index into the risk model, single pTa/T1‐GI Ki‐67 positive tumors, usually classified as low risk, were reclassified as of intermediate risk. After this reclassification, the risk group model identified a subgroup of pTa/T1‐G1 with a high risk of recurrence and progression. Ki‐67 index is a reliable prognostic marker in urothelial superficial bladder carcinoma and, when included into a risk profile classification of the low‐grade USPC, the accuracy of the prognostic discrimination is enhanced.

1 July 1995 in Cancer Genetics and Cytogenetics
Verified
Journal Article
Closed access
Raquel SerucaRaquel Seruca
Raquel Seruca
RSRon F. Suijkerbuijk
Ron F. Suijkerbuijk
FGFátima Gärtner
Fátima Gärtner
Maria Begoña CriadoMaria Begoña Criado
Maria Begoña Criado
IVIsabel Veiga
Isabel Veiga
MSManuel Sobrinho-Simões
Manuel Sobrinho-Simões

13 December 2016 in Genes
Verified
Journal Article
Open access
PDF file
MBMaitane Barasoain
Maitane Barasoain
GBGorka Barrenetxea
Gorka Barrenetxea
IHIratxe Huerta
Iratxe Huerta
MTMercedes Télez
Mercedes Télez
Maria Begoña CriadoMaria Begoña Criado
Maria Begoña Criado
MAMaría Isabel Arrieta
María Isabel Arrieta
Menopause is a period of women’s life characterized by the cessation of menses in a definitive way. The mean age for menopause is approximately 51 years. Primary ovarian insufficiency (POI) refers to ovarian dysfunction defined as irregular menses and elevated gonadotrophin levels before or at the age of 40 years. The etiology of POI is unknown but several genes have been reported as being of significance. The fragile X mental retardation 1 gene (FMR1) is one of the most important genes associated with POI. The FMR1 gene contains a highly polymorphic CGG repeat in the 5′ untranslated region of exon 1. Four allelic forms have been defined with respect to CGG repeat length and instability during transmission. Normal (5–44 CGG) alleles are usually transmitted from parent to offspring in a stable manner. The full mutation form consists of over 200 repeats, which induces hypermethylation of the FMR1 gene promoter and the subsequent silencing of the gene, associated with Fragile X Syndrome (FXS). Finally, FMR1 intermediate (45–54 CGG) and premutation (55–200 CGG) alleles have been principally associated with two phenotypes, fragile X tremor ataxia syndrome (FXTAS) and fragile X primary ovarian insufficiency (FXPOI).

22 September 2024 in Applied Biosciences
Verified
Journal Article
Open access
PDF file
NONatália M. de Oliveira
Natália M. de Oliveira
Jorge Pereira MachadoJorge Pereira Machado
Jorge Pereira Machado
Maria Helena Chéu Guedes VazMaria Helena Chéu Guedes Vaz
Maria Helena Chéu Guedes Vaz
Lara LopesLara Lopes
Lara Lopes
Maria Begoña CriadoMaria Begoña Criado
Maria Begoña Criado
The olive tree is currently cultivated worldwide, with higher incidence in Mediterranean Basin. Its climate is highly favorable to the synthesis of phenolic compounds, stored in olive leaves; their consumption has been linked to a lower incidence of cancer and cardiovascular disorders for which the research interest upon this feature has increased in last decade. This study aimed (i) to review evidence about the importance of olive leaf extract (OLE) on human health and the physiological effect of its major compounds; (ii) to update the state of the art of studies conducted on the health and technological usage of olive leaf extract; (iii) to report potential uses of OLE in pharmaceuticals, food production, and cosmetics; and (iv) to prospect the future of clinical applications of OLE from diverse cultivars, especially in metabolic inflammatory conditions such as polycystic ovary syndrome (PCOS). Overall, cultivars richer in TPC, including TFC, αT, omega-3 and omega-9, present a main research target for supplementation alone or in conjunction with vitaminic compounds, due to their nutraceutical value in metabolic disorders, chronic inflammatory diseases, and anti-aging treatments, whereas cultivars with less water content might be useful as substrates for food preservation. With regard to future prospects, it would be of great interest to clarify the specific mechanisms underlying the beneficial effects of OLE on neuro-immune and cardiovascular health to design safer and healthier nature-based medicine for a wide array of costly and highly prevalent chronic diseases, such as inflammatory and metabolic-related syndromes, namely, PCOS.

1 November 2021 in Complementary Therapies in Clinical Practice
Verified
Journal Article
Closed access
Catarina Ramos PereiraCatarina Ramos Pereira
Catarina Ramos Pereira
Maria Begoña CriadoMaria Begoña Criado
Maria Begoña Criado
JMJorge Machado
Jorge Machado
CPCarlos Trigo Pereira
Carlos Trigo Pereira
MSMaria João Santos
Maria João Santos

1 May 2013 in Gene
Verified
Journal Article
Closed access
MBMaitane Barasoain
Maitane Barasoain
GBGorka Barrenetxea
Gorka Barrenetxea
IHIratxe Huerta
Iratxe Huerta
MTMercedes Télez
Mercedes Télez
ACAmaia Carrillo
Amaia Carrillo
IAIsabel Arrieta
Isabel Arrieta